Clinical trial Recruiting at 1 site Observational Ages 19 and up

Evaluating new and existing drug-eluting stents in everyday clinical practice

Official title: Evaluation of Effectiveness and Safety of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice

Run by CardioVascular Research Foundation, Korea · NCT01186133 · Data updated 2026-11-12

This study tests how well a new type of heart stent works compared to older ones for patients with coronary artery disease who need a procedure to open blocked arteries.

More Coronary Artery Disease trials

Quick facts

Study typeObservational
Ages19 Years and up
SexAll
Enrollment50000 (estimated)
SponsorCardioVascular Research Foundation, Korea
Academic / other
Locations1 site (Multiple Locations)
StatusRecruiting
StartedJanuary 2009
Main results expectedDecember 2030
Study endsDecember 2030
Registry record updatedJune 30, 2026
Trial IDNCT01186133 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are patients with coronary disease that can be treated with percutaneous coronary intervention and who meet the study's inclusion criteria.

Probably not a fit

Patients with terminal illnesses or those experiencing cardiogenic shock may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to assess the effectiveness and safety of a new drug-eluting stent (DES) compared to earlier generations of DES in real-world clinical settings. It involves consecutive patients who receive the new DES without the use of other types of stents. The study focuses on patients with coronary artery disease who are eligible for percutaneous coronary intervention (PCI). By analyzing outcomes in a routine clinical practice environment, the study seeks to provide insights into the performance of these stents.

Why it matters

Potential benefit: If successful, this study could lead to improved treatment options for patients with coronary artery disease.

How similar studies have gone: Other studies have shown success in evaluating drug-eluting stents, but this specific comparison in routine practice may provide novel insights.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* coronary disease amenable to percutaneous coronary intervention (PCI)
* no clinical and lesion limitations

Exclusion Criteria:

* patients with a mixture of several DES
* terminal illness with life expectancy less than 1 year
* patients with cardiogenic shock

Where it's running

  • Korean centres
    Multiple Locations, South Korea
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.